A detailed history of Elgethun Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Elgethun Capital Management holds 22,324 shares of JNJ stock, worth $3.46 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
22,324
Previous 22,387 0.28%
Holding current value
$3.46 Million
Previous $3.54 Million 7.88%
% of portfolio
0.9%
Previous 0.97%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $9,095 - $9,940
-63 Reduced 0.28%
22,324 $3.26 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $255,802 - $268,195
1,648 Added 7.95%
22,387 $3.54 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $1.21 Million - $1.36 Million
-7,776 Reduced 27.27%
20,739 $3.23 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $43,218 - $46,510
-280 Reduced 0.97%
28,515 $4.72 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $294,094 - $350,966
-1,947 Reduced 6.33%
28,795 $4.46 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $29,797 - $33,440
186 Added 0.61%
30,742 $5.43 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $150,036 - $166,953
930 Added 3.14%
30,556 $4.99 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $35,151 - $38,876
209 Added 0.71%
29,626 $5.25 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $103,423 - $117,451
654 Added 2.27%
29,417 $5.21 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $111,178 - $123,356
-713 Reduced 2.42%
28,763 $4.9 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $44,574 - $49,533
276 Added 0.95%
29,476 $4.76 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $78,464 - $84,166
492 Added 1.71%
29,200 $4.81 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $86,484 - $96,321
565 Added 2.01%
28,708 $4.72 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $70,611 - $81,050
515 Added 1.86%
28,143 $4.43 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $9,265 - $10,152
-66 Reduced 0.24%
27,628 $4.11 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $413,093 - $498,720
-3,207 Reduced 10.38%
27,694 $3.77 Million
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $8,891 - $12,319
80 Added 0.26%
30,901 $4.05 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $2,295 - $2,635
18 Added 0.06%
30,821 $4.5 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $27,040 - $30,275
213 Added 0.7%
30,803 $4.01 Million
Q2 2019

Aug 08, 2019

BUY
$131.15 - $144.24 $8,262 - $9,087
63 Added 0.21%
30,590 $4.26 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $12,572 - $13,979
-100 Reduced 0.33%
30,527 $4.27 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $341,986 - $411,586
-2,784 Reduced 8.33%
30,627 $3.92 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $13,860 - $16,288
114 Added 0.34%
33,411 $4.64 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $160,354 - $176,953
1,343 Added 4.2%
33,297 $4.03 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $124,724 - $147,695
997 Added 3.22%
31,954 $4.1 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $94,740 - $103,693
722 Added 2.39%
30,957 $4.33 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $3.91 Million - $4.09 Million
30,235
30,235 $3.93 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Elgethun Capital Management Portfolio

Follow Elgethun Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.